stay updated with our newsletter

Subscribe
Facebook Twitter Linkedin

Month: February 2026

GLP-1 Weight-Loss Drugs and Optic Nerve Risks: What Clinicians and Patients Should Know

The rapid global adoption of glucagon-like peptide-1 (GLP-1) receptor agonists-such as semaglutide (Ozempic®, Wegovy®) and related agents-has reshaped the pharmaceutical management of diabetes and obesity. As their use has expanded to tens of millions worldwide, post-marketing surveillance has begun to identify rare but serious adverse events that warrant careful clinical scrutiny. One emergingRead

Precision Medicine & CBC Setpoints

A retrospective analysis published in the journal Nature suggests that among healthy adults, the CBC (complete blood count) remains stable and fluctuates only very narrowly around individual-specific setpoints. Rather than “one size fits all” reference ranges, these setpoints are associated with mortality and disease risk, even within normal reference ranges. This new understanding mayRead

Preventing Cancer Progression and Metastasis: The Role of Modified Citrus Pectin in Targeting Galectin-3

MCP has demonstrated significant anticancer activity in vitro, in animal studies, and in clinical studies. Beyond its anticancer properties, MCP is shown to improve metal detoxification, immune function, cardiovascular function, and reduce fibrosis to the kidney, liver, and adipose tissue. Together, this body of evidence positions MCP as a promising, multi-targeted intervention with applications in oncology and chronic disease management.

Fueling Endogenous Resolvin Production with High Absorption Omega-3s

The omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have long been known to provide significant health benefits. More recently, a molecular mechanism has emerged that explains how they support a healthy inflammatory response. It’s also clear that to trigger this anti-inflammatory mechanism, a sufficient amount of bioavailableRead

The Great Masquerader: Mycotoxins in Clinical Practice

Mycotoxins—termed the “Great Masquerader” by the WHO—may underlie chronic inflammatory, neurologic, endocrine, and immune conditions. This clinical review outlines mechanisms, laboratory testing limitations, systemic effects, and evidence-informed treatment strategies for functional and integrative practitioners.

The Role of Garlic in Managing Metabolic Syndrome and PCOS

Studies have shown that garlic addresses the overlapping pathogenic mechanisms of MetS and PCOS. Bioactive compounds in garlic, including allicin, can impact oxidative stress, apoptosis, inflammation, and vascular remodeling. A 2023 systematic review and meta-analysis of 19 RCTs concluded that garlic favorably impacts MetS variables, including serum lipids, blood pressure, and body composition.

Xeya Modern Shatavari™ New Published Study Highlights Comprehensive Support for Ovarian Function, Metabolic Health, and Hormone Balance—Areas Critical to Millions of Women

January 13, 2026 (Edison, NJ): As the market surges for botanicals targeting women’s health, new clinical findings set Xeya Modern Shatavari™ apart in the rapidly expanding category. NXT USA is pleased to report that a peer-reviewed study published in Food & Nutrition Research shows that the standardized extract significantly improvesRead